Scrip    Clinica    RAJ    Scrip Clinical Research    AnimalPharm
Email ID
Password
Forgotten your password?
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Legislation
|
Business
|
Products
|
Generics
EVENTS
Today
Cambridge, UK
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
JOB OF THE WEEK Promote your vacancy here
DIRECTORY Scrip Directory 2009
Around 300 drugs exempt from regular price cut under new Japanese provisions
10 March 2010
Around 300 products will escape a reduction in the next regular revision of reimbursement prices for prescription drugs in Japan on April 1st because they meet certain criteria under complex new rules being adopted on a trial basis this ...
 
US FDA issues two new clinical trial design guidances
04 March 2010
The US FDA has issued two new draft guidance documents regarding clinical trial designs: Guidance for Industry: Adaptive Design Clinical Trials for Drugs and Biologics, and Guidance for Industry: Non-inferiority Clinical Trials. The guidances, published in the Federal Register on February 26th and ...
Takeda's pipeline continues to shift towards oncology
15 February 2010
Takeda has given further details of two new in-house projects in early clinical development in the oncology area, which signal its increasing research emphasis on this therapeutic sector. The Japanese firm is looking to build up its presence in cancer given the growth in the field in general and ...
 
FDA criminal division may increase misdemeanour prosecutions against execs
10 March 2010
The US FDA may in the future look to increase prosecution of "responsible corporate officials" in both the pharmaceutical and food industry, Commissioner Margaret Hamburg has stated in a letter, which followed a scathing new government report citing a severe lack of oversight in how the agency ...
Around 300 drugs exempt from regular price cut under new Japanese provisions
10 March 2010
Around 300 products will escape a reduction in the next regular revision of reimbursement prices for prescription drugs in Japan on April 1st because they meet certain criteria under complex new rules being adopted on a trial basis this year. Details of the revision released by the ministry of ...
 
Counterfeiters beware: WHO shows poor countries how to procure antimalarials
10 March 2010
Establishments that produce substandard or counterfeit antimalarials will find it harder to sell their products to developing countries after the World Health Organization published new guidelines this week spelling out how to buy quality-made artemisinin-based combination therapies (ACTs), the ...
Indian expert group to re-examine spurious drug definitions
03 March 2010
India has constituted an expert group to examine the definitions of spurious, adulterated and misbranded drugs in the Drugs and Cosmetic Act and recommend changes to these in the context of "present trade practices followed nationally and internationally". India's Drugs Technical Advisory Board ...
 
EXPERT VIEW
Nurturing innovation through mergers – by Fred Hassan
08 March 2010
Fred Hassan
Following the latest round of pharma mergers and as a long-time participant in this ...

Market Insight: Big pharma hit by Greece's fiscal crisis
09 March 2010

Hospitals' failure to pay pharmaceutical companies and newly announced price cuts are just some of ...

 Market Insight - Fear gives way to prudence a...

Market Insight - Pharma sector in Turkey to shrink 25% under tough conditions
02 March 2010

The pharmaceutical industry has long eyed Turkey as one of its key emerging markets, but recent ...

Market Insight - Power of observation propels comparative effectiveness research into the mainstream
02 March 2010

US agencies are making inroads in the use of comparative effectiveness research to support more ...

Private investment round-up: January 2010
16 February 2010
Private investments began 2010 in a much more positive fashion than at the start of 2009, but were ...

European Medicines Agency and logos: snakes, DNA and the pestle and mortar
22 December 2009
Elizabeth Sukkar
Logos are said to be an important part of an organisation's branding. Really good logos contribute ...

Face to Face with Sandoz's "growth guy" Jeff George
04 March 2010
Eleanor Malone
Jeff George took over as head of Sandoz, Novartis's generics business, in late 2008. With a big ...

Focus on Pharmaceutical Sales
26 September 2008
Section 1 - Dodging the bullet - Pharmaceutical and biotech companies are particularly vulnerable ...

© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Scrip
Clinica
RAJ
Scrip Clinical Research
Animal Pharm